Apr 21, 2020
Hoth Therapeutics Announces Top Line Preclinical Data from Cutaneous Lupus Erythematosus (CLE) Study
Apr 15, 2020
FDA Grants Fast Track Designation to RemeGen's Telitacicept as a Treatment for Systemic Lupus Erythematosus
Apr 01, 2020
Global Systemic Lupus Erythematosus Report, 10-Year Forecasts, 7MM Coverage and Detailed Pipeline Product Profiles
Mar 12, 2020
Provention Announces Positive Data from Phase 1b PREVAIL Study of PRV-3279
Nov 15, 2019
RemeGen, Ltd. Announces Positive Results from Phase IIb Clinical Trial in Systemic Lupus Erythematosus
Nov 10, 2019
Lupus Research Alliance Response to Positive Trial Testing Obinutuzumab (Gazyva®) for Lupus Nephritis
Aug 08, 2019
Provention Bio Initiates Phase 1b/2a PREVAIL Clinical Trial Evaluating PRV-3279 in Lupus
May 29, 2019
Lupus LA Launches Powerful Campaign Promoting Community in the Fight to Cure Lupus
Jan 16, 2019
Histofluor® Rodent Tissue Slides receive FDA 510(k) clearance
Dec 06, 2018
Berlin Cures' Steering Committee is Assembled to Facilitate the Design and Implementation of Phase 2 Study of BC 007
Nov 15, 2018
Opportunity Analysis on the Global Systemic Lupus Erythematosus Market (2018-2025) - Expected to Exhibit a CAGR of 7%
Oct 21, 2018
DxTerity Announces Presentations from Lupus and Multiple Sclerosis Studies at the 2018 ACR/ARHP Annual Meeting
Oct 09, 2018
Global Systemic Lupus Erythematosus Market and Competitive Landscape 2014-2018 & 2023
Sep 12, 2018
SLE Market Size Worth $3.08 Billion by 2025 | CAGR 7.0%: Grand View Research, Inc.
Aug 22, 2018
Berlin Cures Announces Successful Completion of Phase 1 Study of BC 007 for the Treatment of Cardiomyopathy
Jun 07, 2018
DxTerity Announces Preliminary Results from the LIFT Study will be Presented at the 2018 Annual European Congress of Rheumatology
May 23, 2018
Berlin Cures Announces Formation of Scientific Advisory Board
May 09, 2018
Provention Bio Announces Agreements with MacroGenics for Two Clinical-Stage Assets for the Treatment of Autoimmune Disorders
Feb 26, 2018
Heart Failure Treatment from Berlin Cures Shows Promise in Phase 1 Study
Nov 06, 2017
New GSK Multi-country Survey Reveals Need for Improved Awareness Around Long-term Impact and Appropriate use of Corticosteroids in SLE Management